| Literature DB >> 29105856 |
Stacey Webster1, Kerry M O'Rourke2, Conor Fletcher1, Sally L Pimlott3, Andrew Sutherland2, Ai-Lan Lee1.
Abstract
Radiopharmaceuticals that incorporate radioactive iodine in combination with single-photon emission computed tomography imaging play a key role in nuclear medicine, with applications in drug development and disease diagnosis. Despite this importance, there are relatively few general methods for the incorporation of radioiodine into small molecules. This work reports a rapid air- and moisture-stable ipso-iododeboronation procedure that uses NIS in the non-toxic, green solvent dimethyl carbonate. The fast reaction and mild conditions of the gold-catalysed method led to the development of a highly efficient process for the radiolabelling of arenes, which constitutes the first example of an application of homogenous gold catalysis to selective radiosynthesis. This was exemplified by the efficient synthesis of radiolabelled meta-[125 I]iodobenzylguanidine, a radiopharmaceutical that is used for the imaging and therapy of human norepinephrine transporter-expressing tumours.Entities:
Keywords: aryl iodides; gold catalysis; iodination; radiochemistry; radiopharmaceuticals
Year: 2017 PMID: 29105856 PMCID: PMC5814724 DOI: 10.1002/chem.201704534
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236
Scheme 1A) Gold‐catalysed protodeboronation/cross couplings. B) Gold‐catalysed and uncatalysed iododeboronation. C) Gold‐catalysed radioiododeboronation.
Solvent and temperature screen.
|
| ||||
|---|---|---|---|---|
| Entry[a] | Solvent |
| Yield [%][b] |
|
| 1 | CDCl3 | 70 | 60 | 86:14:0 |
| 2 | CDCl3 | 90 | 77 | 93:7:0 |
| 3 | DMC[d] | 90 | 80 | 93:7:0 |
| 4 | toluene | 90 | 77 | 59:23:18 |
| 5 | THF | 90 | 50 | 93:7:0 |
| 6 | acetone | 90 | 21 | complex mixture |
| 7 | dioxane | 90 | 80 | 87:13:0 |
| 8 | water | 90 | – | mainly |
[a] Reaction was carried out on a 0.1 mmol scale. Solvents were not anhydrous. [b] Combined yield of 3 a+4 a+2 a. [c] Determined by 1H NMR analysis. [d] DMC=dimethyl carbonate.
Temperature, time, and equivalents screen.
|
| |||||
|---|---|---|---|---|---|
| Entry[a] |
|
| NIS equiv | Yield [%][b] |
|
| 1 | 70 | 10 | 1.1 | 93 | 75:25 |
| 2 | 90 | 10 | 1.1 | 100 | 86:14 |
| 3 | 100 | 5 | 1.1 | 91 | 91:9 |
| 4 | 100 | 2 | 1.1 | 99 | 90:10 |
| 5 | 100 | 5 | 1.0 | 88 | 95:5 |
|
|
|
|
|
|
|
[a] Reaction carried out on 0.1 mmol of 1 b. [b] Combined yield of 3 b+4 b. [c] Determined by 1H NMR analysis.
Substrate scope.
|
|
|---|
|
|
[a] Yield of isolated product. [b] Thermal heating. [c] Temperature increased to 100 °C. [d] Inseparable unidentified side product observed. [e] 4 Å molecular sieves added. [f] 50 % yield after 5 min. [g] 1:1 ratio of 3 l and α‐iodination product. [h] 1:1 ratio of 3 m and homocoupled product 4,4′‐difluoro‐1,1′‐biphenyl. [i] Carried out with 1.1 equivalents of NIS.
Optimisation of gold‐mediated radioiodination of boronic acid 1 b.[a]
|
| |||
|---|---|---|---|
| Entry |
| PPh3AuNTf2 [mol %] | RCY [%] |
| 1 | 5 | 50 | 63 |
| 2 | 15 | 50 | 96 |
| 3 | 20 | 50 | 100 |
| 4 | 20 | 0 | 47 |
[a] All reactions were performed with a 4–6 MBq solution of [125I]NaI in water (0.01 mL). Reactions were performed under thermal heating conditions in a sealed tube.
Figure 1Chromatograph obtained by analytical radio‐HPLC (blue) of the reaction mixture from the radioiodination of boronic acid 1 b, which shows a quantitative yield of radioiodide incorporation. An overlay of the UV/Vis HPLC trace (black) of product 3 b is also shown.
Substrate scope of gold‐mediated radioiododeboronation.
|
|
|---|
|
|
[a] After 125I‐iododeborination, a second step that involved HCl‐mediated removal of the Boc‐protecting groups was performed to generate [125I]MIBG.
Scheme 2Radiosynthesis of [125I]MIBG (5).